Korean J Urol.
2004 Oct;45(10):1062-1065.
Complete Remission of Renal Cell Carcinoma with Metastases to Lung and Bone Following Initial Interferon-alpha Immunotherapy and Adjuvant Nephrectomy
- Affiliations
-
- 1Department of Urology, Seoul Veterans Hospital, Seoul, Korea. hb0282@hanmail.net
Abstract
- Patients with metastatic renal cell carcinomas have a median survival of less than 1 year and a 0-20% 5-year survial. The immunotherapy agent interferon-alpha has consistently produced objective responses rarely exceeding 20% of treated patients. Moreover, in patients with metastases to brain, liver or bone, the prognosis is extremely poor. A 66-year-old man, with a right renal cell carcinoma, with metastases to lung and bone who had entered a remarkable complete radiological remission of the metastases to lung and bone by 82 months following interferon-alpha immunotherapy, underwent a nephrectomy. The patient has remained recurrence free for 16 months after the nephrectomy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Combined Effect of Angioinfarction with Immunotherapy in Patients with Stage IV Renal Cell Carcinoma
- Application of Autologous Tumor Vaccine as an Adjuvant Immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma
- Three Cases of Childhood Renal Cell Carcinoma Including 2 Cases with Systemic Immunotherapy
- Effects of Nephrectomy and Interferon Administration on Immunological Parameters in Patients with Renal Cell Carcinoma
- Factors Modulating Responses to Immunochemotherapy in Advanced Renal Cell Carcinomas
